open, non comparative trial to asses efficacy and safety of rovamycin forte in the treatment of acute pharyngitis

ABSTRACT

A prospective, non-comparative, open ended clinical trial was conducted on forty patients suffering from symptoms and signs of acute pharangitis, in the department of ENT, JPMC, Karachi. The objective of the study was to evaluate the efficacy and tolerance of Spiramycin [Rovamycin Forte], symbolised by M/s Rhone Poulenc-Ruhr. This study describes the details of the procedure adopted. The results showed that Rovamycin Forte [Spiramycin] is a good choice in come URTI such as acute pharangitis